Bioabsorbable Stents Market Outlook:
Bioabsorbable Stents Market size was USD 1.3 billion in 2024 and is projected to reach USD 6.8 billion by the end of 2037, registering at a CAGR of 17.2% during the forecast period, i.e., 2025-2037. In 2025, the industry size of bioabsorbable stents is estimated at USD 1.7 billion.
The worldwide patient pool in the market is readily increasing, owing to a rise in the prevalence of cardiovascular disorders, with ischemic heart disease affecting an estimated 198 million people globally. Besides, coronary interventions utilizing bioabsorbable stents are also increasing at an approximate 8.5% yearly rate, which is attributed to boosted diagnostic rates and aging populations, especially in emerging economies. Besides, the supply chain aspect for the market includes customized polymer, along with metal alloy raw materials, with 65% to 75% of high-purity and medical-grade polymers sourced from Japan, Germany, and the U.S. The production of active pharmaceutical ingredients (APIs) for drug-eluting bioabsorbable stents is concentrated in administrative markets, based on strict good manufacturing practice (GMP) policies.
Furthermore, the producer price index (PPI) has surged by 4.4% year-over-year (YoY) for the market between 2023 and 2024, which has effectively reflected an increase in raw materials and research and development expenses. Likewise, the consumer price index (CPI) for these devices has also increased by 3.9% yearly, which is readily influenced by hospital procurement and delays in the supply chain. Besides, international trade data has indicated that the EU and the U.S. jointly account for almost 78% of bioabsorbable stent exports, while Asia-Pacific dominates imports, owing to localized assembly, thereby suitable for uplifting the market across different nations.
